A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial...

Por Miller, K. D., O’Neill, A., Perez, E. A., Seidman, A. D., Sledge, G. W.
Publicado em 2012

Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840

Por Lichtman, S. M., Hurria, A., Cirrincione, C. T., Seidman, A. D., Winer, E., Hudis, C., Cohen, H. J., Muss, H. B.
Publicado em 2012

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

Por Fornier, M. N., Morris, P. G., Abbruzzi, A., D'Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A. D., Sklarin, N., Chang, J., Norton, L., Hudis, C. A.
Publicado no Ann Oncol (2011)